When the tumor shrinks but the burden may persist: redefining therapeutic success in tenosynovial giant cell tumor

Journal of Cancer Research and Clinical Oncology · Published 2026-05-18 · DOI 10.1007/s00432-026-06507-8

Free full text

Authors (2)

Qinghua Ke, Shiqiong Zhou

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2026

Citation

Ke, Q., Zhou, S. (2026). When the tumor shrinks but the burden may persist: redefining therapeutic success in tenosynovial giant cell tumor. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-026-06507-8

Related articles

• Temporal trends and socio-demographic disparities in COPD–lung cancer co-occurrence mortality in the United States: a 22 year analysis (1999–2020) · Journal of Cancer Research and Clinical Oncology · 2026 · Same journal
• Timosaponin AIII-based liposomes loaded with Auranofin for the induction of ferroptosis in anaplastic thyroid carcinoma · Journal of Cancer Research and Clinical Oncology · 2026 · Same journal
• Intensity-modulated radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer: a single-institutional phase II investigator-initiated nonrandomized clinical trial · Journal of Cancer Research and Clinical Oncology · 2026 · Same journal
• The transcription factor ZNF217 drives hepatocellular carcinoma progression by activating de novo lipid synthesis via FASN upregulation · Journal of Cancer Research and Clinical Oncology · 2026 · Same journal
• Copy number variants in BRCA1 and BRCA2 genes in Polish patients with breast and ovarian cancer · Journal of Cancer Research and Clinical Oncology · 2026 · Same journal
• Comparison of spread patterns and survival outcomes in uterine carcinosarcoma versus grade 3 endometrioid endometrial cancer · Journal of Cancer Research and Clinical Oncology · 2026 · Same journal
• Years of life lost in cutaneous squamous cell carcinoma: analysis of a prospective cohort of 1400 patients · Journal of Cancer Research and Clinical Oncology · 2026 · Same journal
• Hotspot mutations and tumour spectrum in von Hippel–Lindau syndrome: genotype–phenotype analysis of a large Chinese cohort · Journal of Cancer Research and Clinical Oncology · 2026 · Same journal
• Integrated multi-omics analysis reveals that tumour cell-intrinsic DCLK1 is associated with an angiogenic tumour microenvironment in cholangiocarcinoma via NF-κB/CXCL5 · Journal of Cancer Research and Clinical Oncology · 2026 · Same journal
• The burden of nasopharyngeal carcinoma in countries of the Association of Southeast Asian Nations (ASEAN), 1990–2023: findings from the Global Burden of Disease Study 2023 · Journal of Cancer Research and Clinical Oncology · 2026 · Same journal